SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-08-063493
Filing Date
2008-03-24
Accepted
2008-03-24 15:30:49
Documents
5
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 TO FORM 10-K d10ka.htm 10-K/A 19119
2 CONSENT OF KPMG LLP dex23.htm EX-23 2279
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9713
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 9687
5 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 4577
  Complete submission text file 0001193125-08-063493.txt   46794
Mailing Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2100 NEW YORK NY 10111 212-994-8200
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-29089 | Film No.: 08706982
SIC: 2836 Biological Products, (No Diagnostic Substances)